Agios Pharmaceuticals reported $0 in Loan Capital for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Alexion Pharmaceuticals ALXN:US $ 2311.6M 31.7M
Alnylam Pharmaceuticals ALNY:US $ 0M 0M
Amgen AMGN:US $ 34133M 4125M
AstraZeneca AZN:LN 18754M 3139M
Bayer BAYN:GR € 33947M 2865M
Biogen BIIB:US $ 7425M 1.2M
Biomarin Pharmaceutical BMRN:US $ 1078.16M 585.6M
Bristol Myers Squibb BMY:US $ 41853M 991M
Daiichi Sankyo 4568:JP Y 183719M 32733M
Eli Lilly And LLY:US $ 15064.4M 1082.1M
Gilead Sciences GILD:US $ 21103M 995M
GlaxoSmithKline GSK:LN 25726M 985M
Immunogen IMGN:US $ 0M 2.08M
JAZZ PHA JAZZ:US $ 1843.68M 225.98M
Merk MRK:US $ 26156M 4519M
Novartis NVS:US $ 28181M 2528M
Pfizer PFE:US $ 50529M 14248M
Puma Biotechnology PBYI:US $ 96M 1M
Regeneron Pharmaceuticals REGN:US $ 715.9M 0.7M
Sarepta Therapeutics SRPT:US $ 694M 7M
Seattle Genetics SGEN:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 522.07M 10.88M
YTE INCY:US $ 31.92M 0.04M